PNMA5 and neoplasm: In our research, we verified that BMP2 signaling activation could promotes LLC cells-induced osteoclast differentiation, and this effect could be blocked by knockdown of Pnma5. PNMA5 can be the downstream target of BMP2 signaling in mediating tumor associated osteoclasgenesis.